Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series

Clinical Case Reports 2026 Open access

Read full text
Authors: Samuel Brown, Jillian Rusbridge, George Follows, Anna Santarsieri
DOI: 10.1002/ccr3.71756
Cited by: 0
References: 16

Abstract

Management of recurrent or atypical lymphoplasmacytic lymphoma poses a significant therapeutic challenge. Here we demonstrate a case series of three patients with atypical presentations of extranodal lymphoplasmacytic lymphoma that each show remarkable and timely responses to Zanubrutinib with a limited side effect profile.

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
Clinical Case Reports
Volume
14
Issue
1
Pages
e71756–e71756
Publication date
1 January 2026
Language
EN